Literature DB >> 11910024

Analysis of serine proteinase-inhibitor interaction by alanine shaving.

Olga Buczek1, Katarzyna Koscielska-Kasprzak, Daniel Krowarsch, Michał Dadlez, Jacek Otlewski.   

Abstract

We analyzed the energetic importance of residues surrounding the hot spot (the P(1) position) of bovine pancreatic trypsin inhibitor (BPTI) in interaction with two proteinases, trypsin and chymotrypsin, by a procedure called molecular shaving. One to eight residues of the structural epitope, composed of two extended and exposed loops, were mutated to alanine(s). Although truncation of the side chains of residues surrounding the P(1) position to methyl groups caused a decrease in Delta G(den) values up to 6.4 kcal mole(-1), it did not influence the overall conformation of the inhibitor. We found that the replacement of up to six residues with alanines was fully additive at the level of protein stability. To analyze the influence of the structural epitope on the association energy, we determined association constants for BPTI variants and both enzymes and applied the additivity analysis. Shaving of two binding loops led to a progressive drop in the association energy, more pronounced for trypsin (decrease up to 9.6 kcal mole(-1)) than chymotrypsin (decrease up to 3.5 kcal mole(-1)). In the case of extensively mutated variants interacting with chymotrypsin, the association energies agreed very well with the values calculated from single mutational effects. However, when P(1)-neighboring residues were shaved to alanine(s), their contribution to the association energy was not fully removed because of the presence of methyl groups and main chain-main chain intermolecular hydrogen bonds. Moreover, the hot spot had a different contribution to the complex stability in the fully shaved BPTI variant compared with the wild type, which was caused by perturbations of the P(1)-S(1) electrostatic interaction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11910024      PMCID: PMC2373526          DOI: 10.1110/ps.3510102

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  35 in total

1.  Inhibition of six serine proteinases of the human coagulation system by mutants of bovine pancreatic trypsin inhibitor.

Authors:  A Grzesiak; I Krokoszynska; D Krowarsch; O Buczek; M Dadlez; J Otlewski
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

2.  Amino-acid substitutions at the fully exposed P1 site of bovine pancreatic trypsin inhibitor affect its stability.

Authors:  D Krowarsch; J Otlewski
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

3.  High-resolution structure of bovine pancreatic trypsin inhibitor with altered binding loop sequence.

Authors:  H Czapinska; J Otlewski; S Krzywda; G M Sheldrick; M Jaskólski
Journal:  J Mol Biol       Date:  2000-02-04       Impact factor: 5.469

4.  Ultrahigh-resolution structure of a BPTI mutant.

Authors:  A Addlagatta; S Krzywda; H Czapinska; J Otlewski; M Jaskolski
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-04-24

5.  Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution.

Authors:  R Huber; D Kukla; W Bode; P Schwager; K Bartels; J Deisenhofer; W Steigemann
Journal:  J Mol Biol       Date:  1974-10-15       Impact factor: 5.469

6.  Thermodynamics and kinetics of single residue replacements in avian ovomucoid third domains: effect on inhibitor interactions with serine proteinases.

Authors:  M W Empie; M Laskowski
Journal:  Biochemistry       Date:  1982-05-11       Impact factor: 3.162

7.  Alanine point-mutations in the reactive region of bovine pancreatic trypsin inhibitor: effects on the kinetics and thermodynamics of binding to beta-trypsin and alpha-chymotrypsin.

Authors:  M J Castro; S Anderson
Journal:  Biochemistry       Date:  1996-09-03       Impact factor: 3.162

8.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

9.  Substitutions at the P(1) position in BPTI strongly affect the association energy with serine proteinases.

Authors:  A Grzesiak; R Helland; A O Smalås; D Krowarsch; M Dadlez; J Otlewski
Journal:  J Mol Biol       Date:  2000-08-04       Impact factor: 5.469

10.  Predicting the reactivity of proteins from their sequence alone: Kazal family of protein inhibitors of serine proteinases.

Authors:  S M Lu; W Lu; M A Qasim; S Anderson; I Apostol; W Ardelt; T Bigler; Y W Chiang; J Cook; M N James; I Kato; C Kelly; W Kohr; T Komiyama; T Y Lin; M Ogawa; J Otlewski; S J Park; S Qasim; M Ranjbar; M Tashiro; N Warne; H Whatley; A Wieczorek; M Wieczorek; T Wilusz; R Wynn; W Zhang; M Laskowski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

View more
  5 in total

1.  How optimal are the binding energetics of barnase and barstar?

Authors:  Ting Wang; Sanja Tomic; Razif R Gabdoulline; Rebecca C Wade
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

Review 2.  Protonation and pK changes in protein-ligand binding.

Authors:  Alexey V Onufriev; Emil Alexov
Journal:  Q Rev Biophys       Date:  2013-05       Impact factor: 5.318

3.  Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases.

Authors:  Marie-Louise Zani; Kévin Baranger; Nicolas Guyot; Sandrine Dallet-Choisy; Thierry Moreau
Journal:  Protein Sci       Date:  2009-03       Impact factor: 6.725

Review 4.  Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).

Authors:  Peter Goettig; Viktor Magdolen; Hans Brandstetter
Journal:  Biochimie       Date:  2010-07-06       Impact factor: 4.079

5.  Mapping protein selectivity landscapes using multi-target selective screening and next-generation sequencing of combinatorial libraries.

Authors:  Si Naftaly; Itay Cohen; Anat Shahar; Alexandra Hockla; Evette S Radisky; Niv Papo
Journal:  Nat Commun       Date:  2018-09-26       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.